Compounding Trends Are Cause for Concern
Emerging trends in compounding ingredients bring unwarranted costs and new potential for risk.
The safety concerns surrounding compound medications are well reported in the media — from a 2012 fungal meningitis outbreak caused by an injectable steroid made at a compounding pharmacy to the tragic death of an infant in 2014 due to exposure to a topical medication. Healthesystems has often reported the serious safety concerns associated with compounds including questionable quality control measures, adverse systemic events related to absorption, and lack of proven efficacy.
To continue reading you must be logged in.